Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT04400851
Brief Title:
Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Official Title:
Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors-A Phase I Study
Study:
NCT04400851
Protocol Section:
NCT04400851